Uromigos Live 2023: NMIBC Updates

By The Uromigos - Last Updated: November 20, 2023

During the second-annual Uromigos Live & Unplugged event, Thomas Powles, MBBS, MRCP, MD; Petros Grivas, MD, PhD; Sia Daneshmand, MD; and Sam Chang, MD, MBA, discussed the latest updates in non-muscle invasive bladder cancer.

Therapies under consideration included nadofaragene firadenovec, pembrolizumab, IL-15 superagonist, atezolizumab, TAR-200, TAR-210, and more.

View the first bladder cancer session of the day on the latest data and updates in frontline bladder cancer.

Post Tags:Uromigos Live 2023-Bladder Cancer